Odyssey Marine Expl (OMEX) 2.24 $OMEX Odyssey Marine

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Odyssey Marine Expl (OMEX) 2.24 $OMEX

Odyssey Marine Exploration Reports First Quarter 2016 Results
GlobeNewswire - Thu May 12, 3:54PM CDT
Odyssey Marine Exploration, Inc. (NASDAQ:OMEX), a pioneer in the field of deep-ocean exploration, reported results for the first quarter ended March 31, 2016.
OMEX: 2.24 (+0.12)

Why Are These 4 Stocks So Volatile Today?
ACCESSWIRE - Mon Apr 11, 9:31AM CDT
These Small Cap Stocks Are Getting Major Attention Today
SGYP: 4.12 (+0.13), CANF: 2.28 (+0.03), OMEX: 2.24 (+0.12), MNKD: 1.17 (+0.03)

Odyssey Marine Exploration Responds to Decision on "Don Diego" Project
GlobeNewswire - Mon Apr 11, 7:36AM CDT
Odyssey Marine Exploration, Inc. (NASDAQ:OMEX), a pioneer in the field of deep-ocean exploration, was informed that the recent decision by the Mexican Secretary of Environment and Natural Resources (SEMARNAT) regarding the "Don Diego" dredging and phosphate sand extraction project resulted in a denial of the application for an environmental license as presented.
OMEX: 2.24 (+0.12)

Odyssey Marine Exploration Reports Fourth Quarter and Full Year 2015 Results
GlobeNewswire - Wed Mar 30, 7:30AM CDT
Odyssey Marine Exploration, Inc. (NASDAQ:OMEX), a pioneer in the field of deep-ocean exploration, reports results for the fourth quarter and full year ended December 31, 2015.
OMEX: 2.24 (+0.12)

Odyssey Marine Exploration Executes Funding Transaction
GlobeNewswire - Tue Mar 22, 7:30AM CDT
Odyssey Marine Exploration, Inc. (NASDAQ:OMEX), a pioneer in the field of deep-ocean exploration, has entered into an agreement with Epsilon Acquisitions LLC (Epsilon), under which it will receive a $3 million loan from Epsilon. The loan has been structured as a one-year interest-bearing note, which is convertible at $5.00 per share, which is the volume-weighted average price of Odyssey's common stock for the five trading day period ending on March 17, 2016.
OMEX: 2.24 (+0.12)

Odyssey Marine Exploration Executes $21 Million Deal, Retires all Bank Debt, and Retains a Financial Interest in Future Shipwreck Projects
GlobeNewswire - Wed Dec 16, 7:30AM CST
Odyssey Marine Exploration, Inc. (NASDAQ:OMEX), a pioneer in the field of deep-ocean exploration, has sold certain intangible and tangible assets primarily related to its shipwreck business for $21 million. As part of the deal Odyssey will retain a 21.25% interest in the future net proceeds from shipwreck projects and an exclusive contract to provide shipwreck search and recovery services. Other assets sold include one-half of Odyssey's interest in Neptune Minerals, Inc. and the building where Odyssey's executive offices are located. The assets were purchased by Monaco Financial, LLC and affiliated entities noted below.
OMEX: 2.24 (+0.12)

Odyssey Marine Exploration Sets Operational Update Conference Call for Wednesday, December 16, 2015, at 10:00 a.m. ET
GlobeNewswire - Tue Dec 15, 4:30PM CST
Odyssey Marine Exploration, Inc. (NASDAQ:OMEX), a pioneer in the field of deep-ocean exploration, will hold a conference call on Wednesday, December 16, 2015, at 10:00 a.m. Eastern time to discuss recent corporate developments and provide a brief operational update.
OMEX: 2.24 (+0.12)

Odyssey Marine Exploration Reports Third Quarter 2015 Results
GlobeNewswire - Fri Nov 06, 6:30AM CST
Odyssey Marine Exploration, Inc. (NASDAQ:OMEX), a pioneer in the field of deep-ocean exploration, reported results for its third quarter ended September 30, 2015.
OMEX: 2.24 (+0.12)

Odyssey Marine Exploration Provides Update for "Don Diego" Phosphate Project and Renegotiates Bank Loan Agreement
GlobeNewswire - Thu Sep 17, 6:30AM CDT
Odyssey Marine Exploration, Inc. (Nasdaq:OMEX), a pioneer in the field of deep-ocean exploration, today provided an update on the "Don Diego" project.
OMEX: 2.24 (+0.12)

Odyssey Marine Exploration Reports Second Quarter 2015 Results
GlobeNewswire - Fri Aug 07, 8:13AM CDT
Odyssey Marine Exploration, Inc. (Nasdaq:OMEX), a pioneer in the field of deep-ocean exploration, reported results for the second quarter ended June 30, 2015.
OMEX: 2.24 (+0.12)

Odyssey Marine Exploration Sets Second Quarter 2015 Conference Call for Friday, August 7, 2015, at 10:00 a.m. ET
GlobeNewswire - Mon Aug 03, 3:59PM CDT
Odyssey Marine Exploration, Inc. (NASDAQ:OMEX), a pioneer in the field of deep-ocean exploration, will hold a conference call on Friday, August 7, 2015, at 10:00 a.m. Eastern time to discuss results for the second quarter ended June 30, 2015.
OMEX: 2.24 (+0.12)

Diverse Business Development Opportunities See a Growth in New Projects Globally - Company Receives Authorization for Representation of a Major Chinese Manufacturing Giant in South America & Africa
PR Newswire - Tue Jun 30, 7:40AM CDT
Even though the business services sector grew at a slower pace for a third straight month in June, new expansion opportunities could lead to new revenue opportunities for Companies focused on worldwide projects versus just U.S. opportunities. Companies in focus today are: CD International Enterprises, Inc. (OTC: CDII), Vringo, Inc. (NASDAQ: VRNG), Vectrus, Inc. (NYSE: VEC), Acacia Research Corporation (NASDAQ: ACTG) and Odyssey Marine Exploration, Inc. (NASDAQ: OMEX)
VEC: 29.85 (+1.16), VRNG: 1.97 (-0.01), OMEX: 2.24 (+0.12), ACTG: 4.43 (+0.11)

Exploraciones Oceanicas Environmental Completes Filing of Documentation for the "Don Diego" Project
GlobeNewswire - Mon Jun 29, 7:30AM CDT
Odyssey Marine Exploration, Inc. (NASDAQ:OMEX), a pioneer in the field of deep-ocean exploration, reported that Exploraciones Oceanicas (ExO), the Mexican company that controls the "Don Diego" offshore phosphate resource, has submitted the necessary documentation to continue the environmental evaluation process for the proposed dredging of phosphate sands as planned. Odyssey controls ExO through the company's 54% ownership in Oceanica Resources.
OMEX: 2.24 (+0.12)

Odyssey Stockholders Approve All Proposals at the 2015 Annual Stockholders Meeting
GlobeNewswire - Thu Jun 11, 8:00AM CDT
Odyssey Marine Exploration, Inc. (Nasdaq:OMEX), a pioneer in the field of deep-ocean exploration, announced today that Odyssey stockholders overwhelmingly approved all of the proposals described in the company's definitive proxy statement filed on April 29, 2015, including the proposal to adopt and approve the Purchase Agreement dated March 11, 2015, which received the affirmative vote of 98.4% of the votes cast, and all other proposals related to the transactions contemplated by the Purchase Agreement.
OMEX: 2.24 (+0.12)

Two Leading Proxy Advisory Firms Issue Recommendations on Proposals to be Considered at Odyssey's 2015 Annual Stockholders Meeting
GlobeNewswire - Fri May 29, 6:30AM CDT
Odyssey Marine Exploration, Inc. (Nasdaq:OMEX), a pioneer in the field of deep-ocean exploration, announced today that two leading independent proxy advisory firms -- Institutional Shareholders Services Inc. ("ISS" and Glass, Lewis & Co., LLC ("Glass Lewis" -- have issued their respective reports recommending that Odyssey stockholders vote FOR Proposal 2 to adopt and approve the Purchase Agreement dated March 11, 2015, and all the transactions contemplated by the Purchase Agreement, as described in the company's definitive proxy statement filed on April 29, 2015. Proxy materials have been distributed to Odyssey stockholders of record on the close of business on April 15, 2015.
OMEX: 2.24 (+0.12)

Odyssey Marine Exploration Down 9.9%, Shares Slide into the Red (OMEX)
Comtex SmarTrend(R) - Thu May 28, 10:20AM CDT
Odyssey Marine Exploration (NASDAQ:OMEX) is one of today's worst performing penny stocks, down 9.9% to $0.40 on 1.3x average daily volume. Thus far today, Odyssey Marine Exploration has traded 266,000 shares, vs. average volume of 201,000 shares per day. The stock has underperformed the Dow (-9.9% to the Dow's -0.4%) and underperformed the S&P 500 (-9.9% to the S&P's -0.4%) during today's trading.
OMEX: 2.24 (+0.12)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Unicycive Faces Legal Heat Amid Stock Tumble

Updated Category News Views 22

Unicycive Therapeutics' Rough Ride In this wild market, sometimes even the most seasoned investors get blindsided. Unicycive Therapeutics (NASDAQ: UNC) shareholders are currently caught in a storm with their stock nose-diving by 39.1% on June 30, 2026. It's like being taken to the cleaners without the decency of a warning. Failed Expectations & FDA Blues Here's the...

Continue Reading
Savvy Moves: Avoiding Pitfalls When Buying Used Vans

Updated Category News Views 14

When you're eyeing a used work van, don't just kick the tires and jot down the mileage—there's a whole backyard BBQ checklist you need to chew through. Tony Collichio, the work van guru from Spencerport, lays it down for us, highlighting key questions to ask before pulling out the checkbook. And let me tell you, these aren’t your everyday 'how does it drive?' queries....

Continue Reading
Effective Youth Hockey Skills: Mastering the Basics

Updated Category News Views 35

Laying Down the Tracks: Essential Foundations in Hockey When it comes to developing youth hockey skills, there's no magic formula or flashy trick that'll make overnight stars out of young players. According to HelloNation's recent piece featuring hockey development expert Dave Maksymiu, it’s all about going back to basics. This seems to be the memo often missed by...

Continue Reading
Parents Nationwide Rally for Youth Online Safety Imperative

Updated Category News Views 35

Ringing the Alarm on Digital Dangers Like trying to herd cats on a wild day at the market, keeping teens safe online is a task as tricky as they come. And now, with over 20,000 parents joining forces, it seems there's a real demand out there for some much-needed consistency in online safeguards across all social media platforms. This isn't just about one platform or...

Continue Reading
FDA Nod for Subcutaneous SKYRIZI in Crohn's Disease

Updated Category News Views 48

AbbVie's Injection Makes Waves in Crohn's Treatment Here's a bit of medicine shake-up for you. AbbVie just snagged FDA approval for its subcutaneous SKYRIZI—specifically designed for adults battling moderately to severely active Crohn's disease. This news isn't just a blip on the radar; it's significant for patients and the healthcare landscape. We're talking about new...

Continue Reading
DCK Reveals Versatile Battery-Powered Garden Tools in 2026

Updated Category News Views 65

Battery-Powered Revolution in Louisville The treadmill of lawn care just took a high-tech spin with DCK Tools strutting their stuff at Equip Exposition 2026. Unrolled at the Kentucky Exposition Center, the event from October 21 to 23 was brimming with their battery-powered wares that aim to take the grunt out of yard work. Game-Changing Range of Garden Tools DCK's decked...

Continue Reading
CSTS Unveils PremierX in NYC: A Bold Entertainment Move

Updated Category News Views 0

Welcome to the New Era of Entertainment Out of the blockbusters and into the open air, eh? On October 30, 2026, CSTS Enterprises flipped the New York skyline into a canvas for their grand kickoff of PremierXTM—a live entertainment brand poised to redefine how we gobble up our music, sport, and art. Now, there's a shot of adrenaline New Yorkers weren't exactly begging...

Continue Reading
DigitalXForce Booms with 514% Growth and Major Backing

Updated Category News Views 143

Massive Growth and Strategic Investment in DigitalXForce Now here’s a company that’s shaking things up—DigitalXForce. Right on the back of a staggering 514% growth, they’ve corralled a strategic investment from Arsenal Growth Equity. If you blink, you might miss just how fast they’re sprinting through the tech landscape. Institutional Support Backing the...

Continue Reading
Amgen's IMDELLTRA® Shows Promise in SCLC Battle

Updated Category News Views 0

Breakthrough Results in SCLC Treatment For years, small cell lung cancer (SCLC) has been the unruly beast in the oncology world, defying treatment advances and keeping survival rates stubbornly low. This nasty foe might just have met its match, folks. Amgen (NASDAQ:AMGN) announced results from their Phase 3 DeLLphi-305 trial that show their drug IMDELLTRA®, when teamed...

Continue Reading
CapCut's AI Tools Reshape Video Content Creation

Updated Category News Views 40

AI Revolution in Marketing Content: CapCut Takes Lead It's like the old guard of marketing has hitched a ride on a rocket. In 2026, CapCut has stomped into the limelight with Better Business Advice giving them a nod for their prowess in AI-driven content creation. This isn't some passing trend; it's a seismic shift in how businesses craft their messages. CapCut ain't just...

Continue Reading

Top 5 Most Recently Viewed Articles

Neurocrine Biosciences Unveils Potential of CRENESSITY™ for CAH

Updated Category News Views 379

Overview of CRENESSITY™ Approval Neurocrine Biosciences, Inc. announced a significant breakthrough with the FDA's approval of CRENESSITY™ (crinecerfont), marking the first new treatment for classic congenital adrenal hyperplasia (CAH) in nearly seven decades. This innovative therapy represents a profound shift in the management of this serious genetic condition that...

Continue Reading
Solidion Tech Hits Pause on S-1 Amid Market Forces

Updated Category News Views 15

Solidion's Strategic Withdrawal: Timing or Tactical Move? Solidion Technology, for all intents and purposes, just took a step back. Now, before we wave our hands in panic, let's stew over why the withdrawal of their S-1 registration might actually be more of a tactical retreat than a sign of sinking ship. They're pulling the plug on this specific filing—not because...

Continue Reading
Exploring the Future of the Couriers Market and AI's Role

Updated Category News Views 461

The Promising Growth of the Global Couriers Market The couriers market is on the brink of transformation, with expected growth of USD 115.9 billion from 2024 to 2028. This remarkable expansion is being driven primarily by advancements in technology and the integration of artificial intelligence (AI) in various logistics processes. During this period, the market is...

Continue Reading
Survey Reveals Growing Advisor Interest in Private Market Allocations

Updated Category News Views 213

Insights Into Private Market Allocations by Advisors A recent survey highlights a transformative trend among investment advisors regarding their allocation strategies. According to the findings by Hamilton Lane, nearly one-third of advisors are aiming to allocate 20% or more of their clients' portfolios to private markets in the near future. This shows a significant...

Continue Reading
Zack Kass: Driving AI Innovation at International Talent Conference

Updated Category News Views 165

Zack Kass: A Visionary Leader in AI Zack Kass, a prominent AI strategist and executive business advisor, is set to be the keynote speaker at the 2026 International Conference & Exposition organized by the Association for Talent Development. This global event, at the Los Angeles Convention Center, is expected to attract thousands of attendees aiming to explore the latest...

Continue Reading